Angiogenesis is essential for the growth and metastasis of solid tumors. Th
e balance of endothelial cell (EC) proliferation and apoptosis is a major d
eterminant in tumor angiogenesis. Recently, several studies demonstrated th
at numerous angiogenic factors not only induce angiogenesis but also functi
on as EC survival factors. Vascular endothelial growth factor (VEGF), a pot
ent angiogenic factor, is also an EC survival factor in embryonic vasculoge
nesis and tumor angiogenesis. VEGF activates specific intracellular surviva
l pathways in ECs including Bcl-2, A1, IAP, Akt, and Erk. Integrins may fun
ction as EC survival factors by preventing anoikis by enhancing binding to
the extracellular matrix. In addition, integrins may function in concert wi
th VEGF to promote EC survival. Angiopoietin-1 (Ang-1) has recently been sh
own to stabilize EC networks by binding to the EC-specific tyrosine kinase
receptor Tie-2. Pericytes also function as EC survival factors, by cell-cel
l contact, secretion of survival factors, or both. Targeting any of the abo
ve mechanisms for EC survival may provide novel antineoplastic strategies.